Track the 대웅제약 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 대웅제약 has published 45 reports. The latest transaction was filed on 7 July 2026 (Purchase). Among the most active insiders: 국민연금공단. The full history is free.
45
Insider Decl.
n/a
Thresholds
n/a
16 ops.
Buy Volume
n/a
2 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Daewoong Pharmaceutical is a South Korean pharmaceutical company focused on the development and manufacturing of medications. It is listed on the Korea Exchange, XKRX.